Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease
Authors
Keywords
-
Journal
Frontiers in Cellular Neuroscience
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-11-11
DOI
10.3389/fncel.2014.00369
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low Levels of Soluble NG2 in Cerebrospinal Fluid from Patients with Dementia with Lewy Bodies
- (2018) Henrietta M. Nielsen et al. JOURNAL OF ALZHEIMERS DISEASE
- Total Prion Protein Levels in the Cerebrospinal Fluid are Reduced in Patients with Various Neurological Disorders
- (2017) Felix Meyne et al. JOURNAL OF ALZHEIMERS DISEASE
- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Genomic and Pharmacogenomic Biomarkers of Parkinson’s Disease
- (2014) Hortensia Alonso-Navarro et al. CURRENT DRUG METABOLISM
- Tau protein, beta-amyloid1–42 and clusterin CSF levels in the differential diagnosis of Parkinsonian syndrome with dementia
- (2014) Hana Přikrylová Vranová et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease
- (2014) Lucilla Parnetti et al. MOVEMENT DISORDERS
- CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders
- (2014) Stefania Mondello et al. PARKINSONISM & RELATED DISORDERS
- Differential role of CSF alpha-synuclein species, tau, and Aβ42 in Parkinson's Disease
- (2014) Lucilla Parnetti et al. Frontiers in Aging Neuroscience
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
- (2013) Jing Zhang et al. ACTA NEUROPATHOLOGICA
- May the Evaluation of Nitrosative Stress Through Selective Increase of 3-Nitrotyrosine Proteins Other Than Nitroalbumin and Dominant Tyrosine-125/136 Nitrosylation of Serum α-Synuclein Serve for Diagnosis of Sporadic Parkinson's Disease?
- (2013) Emilio Fernández et al. ANTIOXIDANTS & REDOX SIGNALING
- Evaluation of the Cerebrospinal Fluid Amyloid-�1-42/Amyloid-�1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
- (2013) Magdalena Nutu et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Reduced α-synuclein levels in cerebrospinal fluid in Parkinson's disease are unrelated to clinical and imaging measures of disease severity
- (2013) K. D. van Dijk et al. EUROPEAN JOURNAL OF NEUROLOGY
- 3-hydroxykynurenine and other Parkinson's disease biomarkers discovered by metabolomic analysis
- (2013) Peter A. LeWitt et al. MOVEMENT DISORDERS
- The glial marker YKL-40 is decreased in synucleinopathies
- (2013) Bob Olsson et al. MOVEMENT DISORDERS
- Cerebrospinal fluid Aβ levels correlate with structural brain changes in Parkinson's disease
- (2013) Mona K. Beyer et al. MOVEMENT DISORDERS
- Changes in endolysosomal enzyme activities in cerebrospinal fluid of patients with Parkinson's disease
- (2013) Karin D. van Dijk et al. MOVEMENT DISORDERS
- Oxysterols and Parkinson's disease: Evidence that levels of 24S-hydroxycholesterol in cerebrospinal fluid correlates with the duration of the disease
- (2013) Ingemar Björkhem et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid and plasma clusterin levels in Parkinson's disease
- (2013) Karin D. van Dijk et al. PARKINSONISM & RELATED DISORDERS
- Combined dementia-risk biomarkers in Parkinson's disease: A prospective longitudinal study
- (2013) Yaroslau Compta et al. PARKINSONISM & RELATED DISORDERS
- CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
- (2013) Megan K. Herbert et al. PARKINSONISM & RELATED DISORDERS
- Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
- (2013) Malin Wennström et al. PLoS One
- Association of Cerebrospinal Fluid β-Amyloid 1-42, T-tau, P-tau181, and α-Synuclein Levels With Clinical Features of Drug-Naive Patients With Early Parkinson Disease
- (2013) Ju-Hee Kang JAMA Neurology
- Serum and cerebrospinal fluid urate levels in synucleinopathies versus tauopathies
- (2012) R. Constantinescu et al. ACTA NEUROLOGICA SCANDINAVICA
- Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders
- (2012) Sara Hall et al. ARCHIVES OF NEUROLOGY
- Elevated Levels of α-Synuclein Oligomer in the Cerebrospinal Fluid of Drug-Naïve Patients with Parkinson's Disease
- (2012) Min Jeong Park et al. Journal of Clinical Neurology
- Cerebrospinal fluid amyloid- and phenotypic heterogeneity in de novo Parkinson's disease
- (2012) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progressive dopamine and hypocretin deficiencies in Parkinson’s disease: is there an impact on sleep and wakefulness?
- (2012) MIRIAM WIENECKE et al. JOURNAL OF SLEEP RESEARCH
- Fe and Cu do not differ in Parkinson's disease: A replication study plus meta-analysis
- (2012) Stefania Mariani et al. NEUROBIOLOGY OF AGING
- Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
- (2012) Chera L Maarouf et al. NEUROLOGICAL RESEARCH
- Aβ1-15/16 as a Potential Diagnostic Marker in Neurodegenerative Diseases
- (2012) Magdalena Nutu et al. NEUROMOLECULAR MEDICINE
- Total CSF α-synuclein is lower in de novo Parkinson patients than in healthy subjects
- (2012) Brit Mollenhauer et al. NEUROSCIENCE LETTERS
- CSF Concentrations of cAMP and cGMP Are Lower in Patients with Creutzfeldt-Jakob Disease but Not Parkinson's Disease and Amyotrophic Lateral Sclerosis
- (2012) Patrick Oeckl et al. PLoS One
- Differential Sialylation of Serpin A1 in the Early Diagnosis of Parkinson’s Disease Dementia
- (2012) Sarah Jesse et al. PLoS One
- Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia
- (2012) Walter Maetzler et al. PLoS One
- Phosphorylated -Synuclein in Parkinson's Disease
- (2012) Y. Wang et al. Science Translational Medicine
- Alpha-synuclein in the Cerebrospinal Fluid Differentiates Synucleinopathies (Parkinson Disease, Dementia With Lewy Bodies, Multiple System Atrophy) From Alzheimer Disease
- (2011) Fuyuki Tateno et al. ALZHEIMER DISEASE & ASSOCIATED DISORDERS
- Complement 3 and Factor H in Human Cerebrospinal Fluid in Parkinson's Disease, Alzheimer's Disease, and Multiple-System Atrophy
- (2011) Yu Wang et al. AMERICAN JOURNAL OF PATHOLOGY
- CSF xanthine, homovanillic acid, and their ratio as biomarkers of Parkinson's disease
- (2011) Peter LeWitt et al. BRAIN RESEARCH
- CSF biomarkers in different phenotypes of Parkinson disease
- (2011) Kurt A. Jellinger JOURNAL OF NEURAL TRANSMISSION
- Biopterin levels in the cerebrospinal fluid of patients with PARK8 (I2020T)
- (2011) Shoko Koshiba et al. JOURNAL OF NEURAL TRANSMISSION
- Tau protein and beta-amyloid1-42 CSF levels in different phenotypes of Parkinson’s disease
- (2011) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- Patterns of levels of biological metals in CSF differ among neurodegenerative diseases
- (2011) Isao Hozumi et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study
- (2011) Brit Mollenhauer et al. LANCET NEUROLOGY
- Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias
- (2011) Lucilla Parnetti et al. MOVEMENT DISORDERS
- DJ-1 and αSYN in LRRK2 CSF do not correlate with striatal dopaminergic function
- (2011) Min Shi et al. NEUROBIOLOGY OF AGING
- CSF α-synuclein does not differentiate between parkinsonian disorders
- (2011) M.B. Aerts et al. NEUROBIOLOGY OF AGING
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- Low level of ventricular CSF orexin-A is not associated with objective sleepiness in PD
- (2011) X. Drouot et al. SLEEP MEDICINE
- Increased concentration of C4d complement protein in the cerebrospinal fluids in progressive supranuclear palsy
- (2010) T. Yamada et al. ACTA NEUROLOGICA SCANDINAVICA
- Alteration of amino acids in cerebrospinal fluid from patients with Parkinson's disease and spinocerebellar degeneration
- (2010) K. Araki et al. ACTA NEUROLOGICA SCANDINAVICA
- Short communication Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
- (2010) T. Müller et al. ACTA NEUROLOGICA SCANDINAVICA
- Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
- (2010) U. Fiszer et al. ACTA NEUROLOGICA SCANDINAVICA
- CLINICAL AND PHARMACOLOGICAL EVALUATION OF THE EFFECTS OF PIRIBEDIL IN PATIENTS WITH PARKINSONISM
- (2010) D. L. Mclellan et al. ACTA NEUROLOGICA SCANDINAVICA
- CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
- (2010) E. Eldrup et al. ACTA NEUROLOGICA SCANDINAVICA
- Determination of acetylcholine concentration in cerebrospinal fluid of patients with neurologic diseases
- (2010) H. Yamada et al. ACTA NEUROLOGICA SCANDINAVICA
- Cerebrospinal fluid nitrate levels in patients with Parkinson's disease
- (2010) J. A. Molina et al. ACTA NEUROLOGICA SCANDINAVICA
- Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson’s disease
- (2010) E.-S. Wang et al. ACTA NEUROLOGICA SCANDINAVICA
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Quantification of cystatin C in cerebrospinal fluid from various neurological disorders and correlation with G73A polymorphism in CST3
- (2010) Yukiko Yamamoto-Watanabe et al. BRAIN RESEARCH
- Polyamine patterns in the cerebrospinal fluid of patients with Parkinson's disease and multiple system atrophy
- (2010) Man-Jeong Paik et al. CLINICA CHIMICA ACTA
- The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
- (2010) M. Andersson et al. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
- L-Dopa therapy increases homocysteine concentration in cerebrospinal fluid from patients with Parkinson’s disease
- (2010) Chiaki Isobe et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson’s disease
- (2010) Farhad Mashayekhi et al. JOURNAL OF CLINICAL NEUROSCIENCE
- CSF markers of neurodegeneration in Parkinson’s disease
- (2010) Hana Přikrylová Vranová et al. JOURNAL OF NEURAL TRANSMISSION
- CSF amyloid- and tau proteins, and cognitive performance, in early and untreated Parkinson's Disease: the Norwegian ParkWest study
- (2010) G. Alves et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients
- (2010) Valerio Pisani et al. MOVEMENT DISORDERS
- Cerebrospinal fluid tau and phosphorylated tau protein are elevated in corticobasal syndrome
- (2010) M.B. Aerts et al. MOVEMENT DISORDERS
- CSF Aβ42and tau in Parkinson's disease with cognitive impairment
- (2010) Thomas J. Montine et al. MOVEMENT DISORDERS
- Detection of elevated levels of -synuclein oligomers in CSF from patients with Parkinson disease
- (2010) T. Tokuda et al. NEUROLOGY
- CSF amyloid 1-42 predicts cognitive decline in Parkinson disease
- (2010) A. Siderowf et al. NEUROLOGY
- High cerebrospinal tau levels are associated with the rs242557 tau gene variant and low cerebrospinal β-amyloid in Parkinson disease
- (2010) Yaroslau Compta et al. NEUROSCIENCE LETTERS
- Cerebrospinal fluid metabolite and nigrostriatal dopaminergic function in Parkinson’s disease
- (2009) K. Ishibashi et al. ACTA NEUROLOGICA SCANDINAVICA
- Urate as a Predictor of the Rate of Clinical Decline in Parkinson Disease
- (2009) Alberto Ascherio ARCHIVES OF NEUROLOGY
- Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia
- (2009) Y. Compta et al. BRAIN
- Proteomic analysis of the cerebrospinal fluid of Parkinson's disease patients
- (2009) Jiguang Guo et al. CELL RESEARCH
- Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson’s disease and major depression
- (2009) Sven Pålhagen et al. JOURNAL OF NEUROLOGY
- Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease
- (2009) Yaroslau Compta et al. MOVEMENT DISORDERS
- Levels of reduced and oxidized coenzymeQ-10 and 8-hydroxy-2′-deoxyguanosine in the cerebrospinal fluid of patients with living Parkinson's disease demonstrate that mitochondrial oxidative damage and/or oxidative DNA damage contributes to the neurodegenerative process
- (2009) Chiaki Isobe et al. NEUROSCIENCE LETTERS
- Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical parkinsonian disorders
- (2009) Radu Constantinescu et al. PARKINSONISM & RELATED DISORDERS
- CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases
- (2008) Jing Zhang et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies
- (2008) Lucilla Parnetti et al. BIOLOGICAL PSYCHIATRY
- Differential distribution of neuregulin in human brain and spinal fluid
- (2008) Mark S. Pankonin et al. BRAIN RESEARCH
- Cerebrospinal fluid-orexin levels and sleep attacks in four patients with Parkinson's disease
- (2008) Hirohide Asai et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Brain-derived neurotrophic factor concentrations in the cerebrospinal fluid of patients with Parkinson’s disease
- (2008) Zivar Salehi et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Free Copper, Ferroxidase and SOD1 Activities, Lipid Peroxidation and NO x Content in the CSF. A Different Marker Profile in Four Neurodegenerative Diseases
- (2008) Marie-Catherine Boll et al. NEUROCHEMICAL RESEARCH
- Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
- (2008) B. Borroni et al. NEUROLOGY
- Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?
- (2008) Annika Öhrfelt et al. NEUROSCIENCE LETTERS
- Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy
- (2008) David S. Goldstein et al. PARKINSONISM & RELATED DISORDERS
- Correlation between changes in CSF dopamine turnover and development of dyskinesia in Parkinson's disease
- (2008) Gianluigi Lunardi et al. PARKINSONISM & RELATED DISORDERS
- Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
- (2007) B. Borroni et al. NEUROBIOLOGY OF AGING
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now